Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fubo Wang

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|March 17, 2012
Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancerShancheng Ren, Chuanliang Xu, Zilian Cui, et al.
Scientific Reports|February 12, 2016
Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancerJia Li, Shancheng Ren, Hai-Long Piao, et al.
Molecular & Cellular Proteomics : MCP|November 8, 2015
Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate CancerShancheng Ren, Yaping Shao, Xinjie Zhao, et al.
American Journal of Cancer Research|October 18, 2021
Effect of <i>APOBEC3A</i> functional polymorphism on renal cell carcinoma is influenced by tumor necrosis factor-α and transcriptional repressor ETS1Xiaojie Tan, Shaoling Zheng, Wenbin Liu, et al.
Urolithiasis|December 22, 2025
Preoperative machine learning algorithm for predicting urosepsis after percutaneous nephrolithotomy using EMR dataBin Liang, Baofei Tan, Zuheng Wang, et al.
Science China. Life Sciences|July 12, 2025
WTAP-mediated m<sup>6</sup>A modification promotes drug sensitivity by regulating NR3C1 in prostate cancerHuifeng Wang, Die Zhang, Yiqiang Ouyang, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 10, 2023
Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancerDepei Kong, Chen Ye, Chenxi Zhang, et al.
The Journal of Urology|July 13, 2013
Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancerShancheng Ren, Yawei Liu, Weidong Xu, et al.
BMC Biotechnology|May 23, 2026
Yeast surface display-based screening and preliminary characterization of nectin-4-targeting nanobodies for bladder cancerJianhua Wen, Liangyi Wei, Jun Huang, et al.
Frontiers in Oncology|May 24, 2021
Serum Metabolic Profiling Identifies a Biomarker Panel for Improvement of Prostate Cancer DiagnosisHuan Xu, Junyi Chen, Jingyi He, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Journal of Molecular Medicine (Berlin, Germany)|March 17, 2012
Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancerShancheng Ren, Chuanliang Xu, Zilian Cui, et al.
Scientific Reports|February 12, 2016
Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancerJia Li, Shancheng Ren, Hai-Long Piao, et al.
Molecular & Cellular Proteomics : MCP|November 8, 2015
Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate CancerShancheng Ren, Yaping Shao, Xinjie Zhao, et al.
American Journal of Cancer Research|October 18, 2021
Effect of <i>APOBEC3A</i> functional polymorphism on renal cell carcinoma is influenced by tumor necrosis factor-α and transcriptional repressor ETS1Xiaojie Tan, Shaoling Zheng, Wenbin Liu, et al.
Urolithiasis|December 22, 2025
Preoperative machine learning algorithm for predicting urosepsis after percutaneous nephrolithotomy using EMR dataBin Liang, Baofei Tan, Zuheng Wang, et al.
Science China. Life Sciences|July 12, 2025
WTAP-mediated m<sup>6</sup>A modification promotes drug sensitivity by regulating NR3C1 in prostate cancerHuifeng Wang, Die Zhang, Yiqiang Ouyang, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 10, 2023
Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancerDepei Kong, Chen Ye, Chenxi Zhang, et al.
The Journal of Urology|July 13, 2013
Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancerShancheng Ren, Yawei Liu, Weidong Xu, et al.
BMC Biotechnology|May 23, 2026
Yeast surface display-based screening and preliminary characterization of nectin-4-targeting nanobodies for bladder cancerJianhua Wen, Liangyi Wei, Jun Huang, et al.
Frontiers in Oncology|May 24, 2021
Serum Metabolic Profiling Identifies a Biomarker Panel for Improvement of Prostate Cancer DiagnosisHuan Xu, Junyi Chen, Jingyi He, et al.
Pageof 10